Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(HBIO, PTSH, FBNC, MSLP, MTEX) Market News From DrStockPick.com!

drstock-2-3

signup3m

ptsh_logo

PTS, Inc. (OTC.BB:PTSH), through its ThinLine division, has signed a 3 year IT Services deal with United Power.

United Power is acknowledged experts on the resale of products especially suited for medium voltage power distribution, in addition to providing a wide portfolio of products for other aspect of the electrical utility business. United Power has been serving electrical utility Customers within Georgia continuously since 1976. They have developed a reputation for customer sensitivity, fair dealing and exceptional quality during this time.

United Power required an IT solution that would allow them to contact one source for all of their IT needs.

"United Power is a well-established and quality company that has been a leader in their field for decades" stated Raj Kalra CEO of PTS. "They were looking for a one stop shop that would be able to handle their IT, disaster recovery and hardware needs without making more than one phone call. ThinLine's managed IT solution was designed for this task. We look forward to working with the team at United Power and I am always excited to add a quality client to our growing portfolio of managed It customers," added Raj Kalra.

***************************************************

MusclePharm Corporation (OTCBB:MSLP) announced a fulfillment agreement with IVitals that is expected to improve cash flow, reduce backorders, improve turnaround time on all orders and allow management to focus its time and resources on the marketing and selling of MusclePharm's growing portfolio of products.

The Company expects to achieve over $4 million in sales for the full year of 2010, which is over 300% growth compared to the same period last year. The rapid growth and strong customer demand for the MusclePharm products has created back orders for 5 of the 12 months in 2010. The new fulfillment agreement is expect to greatly improve the back orders for the remainder of 2010 and reduce the insufficient levels of stock needed to complete all orders.

MusclePharm's President, Cory Gregory stated, "This fulfillment agreement will reduce the cost and delivery time for all product shipments to our many retail and online customers. In addition, by outsourcing our fulfillment function, management will be able to focus our time and resources on expanding sales opportunities and enhancing our brand."

Mr. Gregory continued, "With rapid growth of 300% come a few growing pains such as back orders. I am pleased that we expect to achieve this growth in 2010 despite having 40% of our orders on back-order. However, with this fulfillment agreement, we have greatly improved our operating platform and believe we have rectified our back order situation. With a dramatically improved operating platform and leading nutritional supplements that are 100% free of any banned substances we are very well positioned for continued strong growth in 2011."

MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances.

***************************************************

Mannatech, Incorporated (NASDAQ:MTEX), a global pioneer in the development of high-quality health, weight and fitness and skin care solutions based on nutritional science, recently announced Sergio Medina as managing director of its Mexico business, which is set to open in early 2011.

Mannatech Incorporated engages in the development and sale of nutritional supplements, topical and skin care products, and weight-management products worldwide.

***************************************************

First Bancorp (NASDAQ:FBNC), the parent company of First Bank, announced recently net income available to common shareholders of $2.8 million, or $0.17 per diluted common share, for the three months ended September 30, 2010 and $9.1 million, or $0.54 per diluted common share, for the nine months ended September 30, 2010.

First Bancorp operates as the holding company for First Bank that provides a range of banking services to individuals and small to medium-sized businesses.

***************************************************

Harvard Bioscience, Inc. (NASDAQ:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, recently reported unaudited financial highlights for the three and nine months ended September 30, 2010.

Harvard Bioscience, Inc. develops, manufactures, and markets apparatus and scientific instruments used in life science research in pharmaceutical and biotechnology companies, universities, and government laboratories in the United States and internationally.

****************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for PTS Inc.(OTCPK:PTSH)

Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (OTCQB:MSLP)

drstbc